Last updated: 4 January 2022 at 6:51pm EST

Mostafa Kamal Net Worth




The estimated Net Worth of Mostafa Kamal is at least $13.3 Million dollars as of 3 March 2021. Mr. Kamal owns over 6,242 units of Magellan Health Inc stock worth over $861,179 and over the last 9 years he sold MGLN stock worth over $9,481,283. In addition, he makes $2,911,750 as Chief Executive Officer - Magellan Rx Management at Magellan Health Inc.

Mr. Kamal MGLN stock SEC Form 4 insiders trading

Mostafa has made over 24 trades of the Magellan Health Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 6,242 units of MGLN stock worth $592,928 on 3 March 2021.

The largest trade he's ever made was selling 20,885 units of Magellan Health Inc stock on 13 November 2020 worth over $1,771,466. On average, Mostafa trades about 4,083 units every 47 days since 2015. As of 3 March 2021 he still owns at least 9,066 units of Magellan Health Inc stock.

You can see the complete history of Mr. Kamal stock trades at the bottom of the page.





Mostafa Kamal biography

Mostafa M. Kamal serves as Chief Executive Officer - Magellan Rx Management of the Company. Mr. Kamal previously served as senior vice president and general manager of Magellan Rx Management’s specialty pharmacy business, as well as its chief underwriting officer. From 2011 to 2014, Mr. Kamal was vice president of pricing, underwriting and analytics. Before joining the company, he served as director of strategy and analytics at Medco Health Solutions, Inc. (now known as Express Scripts). He currently serves as a director of the Pharmaceutical Care Management Association.

What is the salary of Mostafa Kamal?

As the Chief Executive Officer - Magellan Rx Management of Magellan Health Inc, the total compensation of Mostafa Kamal at Magellan Health Inc is $2,911,750. There are 1 executives at Magellan Health Inc getting paid more, with Kenneth Fasola having the highest compensation of $4,880,750.



How old is Mostafa Kamal?

Mostafa Kamal is 39, he's been the Chief Executive Officer - Magellan Rx Management of Magellan Health Inc since 2015. There are 14 older and no younger executives at Magellan Health Inc. The oldest executive at Magellan Health Inc is Mural Josephson, 70, who is the Director.

What's Mostafa Kamal's mailing address?

Mostafa's mailing address filed with the SEC is 15950 N 76th St #200, Scottsdale, AZ 85260, USA.

Insiders trading at Magellan Health Inc

Over the last 22 years, insiders at Magellan Health Inc have traded over $207,355,721 worth of Magellan Health Inc stock and bought 25,726 units worth $1,508,914 . The most active insiders traders include Peter A Feld, James E Murray und Mary F Sammons. On average, Magellan Health Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,340,119. The most recent stock trade was executed by James E Murray on 2 January 2022, trading 3,262 units of MGLN stock currently worth $309,857.



What does Magellan Health Inc do?

Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.



What does Magellan Health Inc's logo look like?

Magellan Health Inc logo

Complete history of Mr. Kamal stock trades at Magellan Health Inc

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
3 Mar 2021 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 6,242 $92.85 $579,570
3 Mar 2021
9,066
9 Dec 2020 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 2,793 $79.69 $222,574
9 Dec 2020
2,824
13 Nov 2020 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 20,885 $84.82 $1,771,466
13 Nov 2020
5,617
10 Nov 2020 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 6,000 $81.57 $489,420
10 Nov 2020
5,617
4 Nov 2020 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 7,023 $79.88 $560,997
4 Nov 2020
5,617
16 Oct 2020 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 183 $79.87 $14,616
16 Oct 2020
5,617
3 Mar 2020 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 4,365 $56.03 $244,571
3 Mar 2020
7,158
9 Dec 2019 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 16,766 $78.72 $1,319,820
9 Dec 2019
2,793
3 Mar 2019 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 3,996 $69.42 $277,402
3 Mar 2019
4,509
2 Apr 2018 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 1,666 $106.20 $176,929
2 Apr 2018
0
7 Mar 2018 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 727 $104.00 $75,608
7 Mar 2018
849
5 Mar 2018 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 15,428 $99.04 $1,527,989
5 Mar 2018
0
4 Mar 2018 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 175 $101.75 $17,806
4 Mar 2018
175
4 Dec 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 2,180 $92.00 $200,560
4 Dec 2017
0
1 Nov 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 1,154 $92.00 $106,168
1 Nov 2017
0
28 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 4,848 $85.76 $415,764
28 Sep 2017
0
27 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 19,126 $85.33 $1,632,022
27 Sep 2017
0
15 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 2,961 $84.00 $248,724
15 Sep 2017
0
12 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 604 $83.00 $50,132
12 Sep 2017
0
11 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 670 $83.00 $55,610
11 Sep 2017
0
8 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 6,267 $81.53 $510,949
8 Sep 2017
0
5 Sep 2017 Mostafa Kamal
CEO und Magellan Rx Management
Verkauf 2,190 $81.07 $177,543
5 Sep 2017
0
5 Mar 2017 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 144 $68.50 $9,864
5 Mar 2017
339
4 Mar 2017 Mostafa Kamal
CEO und Magellan Rx Management
Optionausübung 175 $68.50 $11,988
4 Mar 2017
278


Magellan Health Inc executives and stock owners

Magellan Health Inc executives and other stock owners filed with the SEC include: